The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects
Open accessAbstract
Background and aims Abdominal fat accumulation (visceral/hepatic) has been associated with hepatic insulin resistance (IR) in obesity and type 2 diabetes (T2DM). We examined the relationship between visceral/hepatic fat accumulation and hepatic IR/accelerated gluconeogenesis (GNG).Methods In 14 normal glucose tolerant (NGT) (body mass index [BMI] = 25 +/- 1 kg/m(2)) and 43 T2DM (24 nonobese, BMI = 26 +/- 1; 19 obese, BMI = 32 +/- 1 kg/m(2)) subjects, we measured endogenous (hepatic) glucose production (3-(3)H-glucose) and GNG ((2)H(2)O) in the basal state and during 240 pmol/m(2)/min euglycemic-hyperinsulinemic clamp, and liver (LF) subcutaneous (SAT)/visceral (VAT) fat content by magnetic resonance spectroscopy/magnetic resonance imaging.Results LF was increased in lean T2DM compared with lean NGT (18% +/- 3% vs 9% +/- 2%, P < .03), but was similar in lean T2DM and obese T2DM (18% +/- 3% vs 22% +/- 3%; P = NS). Both VAT and SAT increased progressively from lean NGT to lean T2DM to obese T2DM. T2DM had increased basal endogenous glucose production (EGP) (NGT, 15.1 +/- 0.5; lean T2DM, 16.3 +/- 0.4; obese T2DM, 17.2 +/- 0.6 micromol/min/kg(ffm); P = .02) and basal GNG flux (NGT, 8.6 +/- 0.4; lean T2DM, 9.6 +/- 0.4; obese T2DM, 11.1 +/- 0.6 micromol/min/kg(ffm); P = .02). Basal hepatic IR index (EGP x fasting plasma insulin) was increased in T2DM (NGT, 816 +/- 54; lean T2DM, 1252 +/- 164; obese T2DM, 1810 +/- 210; P = .007). In T2DM, after accounting for age, sex, and BMI, both LF and VAT, but not SAT, were correlated significantly (P < .05) with basal hepatic IR and residual EGP during insulin clamp. Basal percentage of GNG and GNG flux were correlated positively with VAT (P < .05), but not with LF. LF, but not VAT, was correlated with fasting insulin, insulin-stimulated glucose disposal, and impaired FFA suppression by insulin (all P < .05).Conclusions Abdominal adiposity significantly affects both lipid (FFA) and glucose metabolism. Excess VAT primarily increases GNG flux. Both VAT and LF are associated with hepatic IR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Except for a recent study of Gastaldelli et al, 17 who found no difference in insulin clearance between lean normal subjects and lean or obese type 2 diabetic patients, there are no studies in which carefully matched groups of type 2 diabetic patients and nondiabetic subjects would have been compared with respect to liver fat, hepatic insulin sensitivity, and insulin clearance.”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [17]
In the citing paper
“In small groups of diabetic patients, insulin clearance has reported to be normal, 16 -18 decreased, 19,20 or even increased.21”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli‐Labate, A. M., Bianchi, G. P., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,570
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
Flagged first, then by citations
2 of the 43 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Matsuda, 1997, Relationship between insulin sensitivity in adipose tissue, liver, muscle and components of the insulin resistance syndrome, Diabetes, 46, 68A
Cited by
Sorted by citations
Items 101–200 of 629
Musso, G., Cassader, M., De Michieli, F., Rosina, F., Orlandi, F., & Gambino, R. (2012) · Hepatology · doi:10.1002/hep.25739 · Cited by 126
Pathophysiology of Type 2 Diabetes in Children and Adolescents
Valaiyapathi, B., Gower, B. A., & Ashraf, A. P. (2019) · Current Diabetes Reviews · doi:10.2174/1573399814666180608074510 · Cited by 160
The role of adipokines in liver fibrosis
Bertolani, C., & Marra, F. (2008) · Pathophysiology · doi:10.1016/j.pathophys.2008.05.001 · Cited by 128
Fatty liver is an independent predictor of early carotid atherosclerosis
Pais, R., Giral, P., Khan, J.-F., Rosenbaum, D. H., Housset, C., Poynard, T., & Ratziu, V. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.023 · Cited by 123
Jin, R., Welsh, J. A., Le, N., Holzberg, J. R., Sharma, P., Martin, D., & Vos, M. B. (2014) · Nutrients · doi:10.3390/nu6083187 · Cited by 122
Vreman, R. A., Goodell, A. J., Rodríguez, L. A., Porco, T. C., Lustig, R. H., & Kahn, J. G. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013543 · Cited by 116
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
Santos, R. D., Valenti, L. V. C., & Romeo, S. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.01.029 · Cited by 115
Stefan, N., Ramsauer, M., Jordan, P., Nowotny, B., Kantartzis, K., Machann, J., Hwang, J., Nowotny, P., KAHL, S., Harreiter, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70170-0 · Cited by 113
Croci, I., Byrne, N. M., Choquette, S., Hills, A. P., Chachay, V., Clouston, A. D., O'Moore‐Sullivan, T. M., Macdonald, G. A., Prins, J. B., & Hickman, I. J. (2012) · Gut · doi:10.1136/gutjnl-2012-302789 · Cited by 119
Hyötyläinen, T., Jerby‐Arnon, L., Petäjä, E. M., Mattila, I. M., Jäntti, S. E., Auvinen, P., Gastaldelli, A., Yki‐Järvinen, H., Ruppin, E., & Orešič, M. (2016) · Nature Communications · doi:10.1038/ncomms9994 · Cited by 114
Pioglitazone in the treatment of NASH: the role of adiponectin
Gastaldelli, A., Harrison, S. A., Belfort‐Aguiar, R., Hardies, J., Balas, B., Schenker, S., & Cusi, K. J. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04405.x · Cited by 115
Knudsen, S. H., Hansen, L. S., Pedersen, M., Dejgaard, T., Hansen, J., Hall, G. V., Thomsen, C., Solomon, T. P. J., Pedersen, B. K., & Krogh-Madsen, R. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00189.2011 · Cited by 112
Saponaro, C., Sabatini, S., Gaggini, M., Carli, F., Rosso, C., Positano, V., Armandi, A., Caviglia, G. P., Faletti, R., Bugianesi, E., et al. (2022) · Liver International · doi:10.1111/liv.15377 · Cited by 116
Adipose tissue changes in obesity and the impact on metabolic function
Sam, S., & Mazzone, T. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.008 · Cited by 113
New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)
Ali, R., & Cusi, K. J. (2009) · Annals of Medicine · doi:10.1080/07853890802552437 · Cited by 111
Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver
Lehmann, R., Franken, H., Dammeier, S., Rosenbaum, L., Kantartzis, K., Peter, A., Zell, A., Adam, P., Li, J., Xu, G., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1760 · Cited by 114
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
Fruci, B., Giuliano, S., Mazza, A., Malaguarnera, R., & Belfiore, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122933 · Cited by 109
Bell, L. N., Wang, J., Muralidharan, S. S., Chalasani, S., Fullenkamp, A. M., Wilson, L., Sanyal, A. J., Kowdley, K. V., Neuschwander‐Tetri, B. A., Brunt, E. M., et al. (2012) · Hepatology · doi:10.1002/hep.25805 · Cited by 106
Gastaldelli, A., Sabatini, S., Carli, F., Gaggini, M., Bril, F., Belfort‐DeAguiar, R., Positano, V., Barb, D., Kadiyala, S., Harrison, S., et al. (2021) · Liver International · doi:10.1111/liv.15005 · Cited by 101
Altered body composition in preterm infants at hospital discharge
Cooke, R. J., & Griffin, I. J. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2009.01354.x · Cited by 100
Barb, D., Bril, F., Kalavalapalli, S., & Cusi, K. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02414 · Cited by 100
Ferreira, D. M. S., Castro, R. E., Machado, M. V., Evangelista, T., Silvestre, A. R., Costa, A., Coutinho, J. R. H., Carepa, F., Cortez‐Pinto, H., & Rodrigues, C. M. P. (2011) · Diabetologia · doi:10.1007/s00125-011-2130-8 · Cited by 102
RetractedGastaldelli, A., Gaggini, M., Daniele, G., Ciociaro, D., Cersosimo, E., Tripathy, D., Triplitt, C., Fox, P., Musi, N., DeFronzo, R., et al. (2016) · Hepatology · doi:10.1002/hep.28827 · Cited by 96
Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?
Gastaldelli, A. (2017) · Clinical Science · doi:10.1042/cs20170987 · Cited by 95
Ebrahimi‐Mameghani, M., Sadeghi, Z., Farhangi, M. A., Vaghef‐Mehrabany, E., & Aliashrafi, S. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.004 · Cited by 94
Fabbrini, E., DeHaseth, D., Deivanayagam, S., Mohammed, B. S., Vitola, B. E., & Klein, S. (2008) · Obesity · doi:10.1038/oby.2008.494 · Cited by 94
Mager, D. R., Rivera‐Íñiguez, I., Gilmour, S. M., & Yap, J. Y. K. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113501201 · Cited by 93
Obesity, visceral fat and Crohnʼs disease
Bertin, B., Desreumaux, P., & Dubuquoy, L. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833cf0f4 · Cited by 91
Differential effect of subcutaneous abdominal and visceral adipose tissue on cardiometabolic risk
Sam, S. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0014 · Cited by 98
Miyazaki, Y., & DeFronzo, R. A. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-44 · Cited by 90
FAT/CD36: A Major Regulator of Neuronal Fatty Acid Sensing and Energy Homeostasis in Rats and Mice
Foll, C. L., Dunn-Meynell, A. A., Musatov, S., Magnan, C., & Levin, B. E. (2013) · Diabetes · doi:10.2337/db12-1689 · Cited by 90
Trouwborst, I., Gijbels, A., Jardon, K. M. C., Siebelink, E., Hul, G. B. J., Wanders, L., Erdõs, B., Péter, S., Singh‐Povel, C. M., den Bosch, J. D. V., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.12.002 · Cited by 90
Measurements of Gluconeogenesis and Glycogenolysis: A Methodological Review
Chung, S. T., Chacko, S. K., Sunehag, A. L., & Haymond, M. W. (2015) · Diabetes · doi:10.2337/db15-0640 · Cited by 88
The metabolic basis of nonalcoholic steatohepatitis
Chakravarthy, M. V., & Neuschwander‐Tetri, B. A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.112 · Cited by 93
Wang, Y., Zhou, M., Lam, K. S. L., & Xu, A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200012 · Cited by 90
Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis
Lomonaco, R., Ortiz‐Lopez, C., Orsak, B., Finch, J., Webb, A., Bril, F., Louden, C., Tio, F. O., & Cusi, K. J. (2011) · Hepatology · doi:10.1002/hep.24483 · Cited by 86
Diabetes and cirrhosis: Current concepts on diagnosis and management
Castéra, L., & Cusi, K. J. (2023) · Hepatology · doi:10.1097/hep.0000000000000263 · Cited by 87
Peter, A., Kovářová, M., Staiger, H., Machann, J., Schick, F., Königsrainer, A., Königsrainer, I., Schleicher, E. D., Fritsche, A., Häring, H., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00262.2017 · Cited by 83
Girard, J. R., & Lafontan, M. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.04.002 · Cited by 83
Stefan, N., Sun, Q., Fritsche, A., Machann, J., Schick, F., Gerst, F., Jeppesen, C., Joost, H., Hu, F. B., Boeing, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092238 · Cited by 80
Obesity and diabetes: the link between adipose tissue dysfunction and glucose homeostasis
Abranches, M. V., de Oliveira, F. C. E., da Conceição, L. L., & Pelúzio, M. D. C. G. (2015) · Nutrition Research Reviews · doi:10.1017/s0954422415000098 · Cited by 78
Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease
Eslamparast, T. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v7.i2.204 · Cited by 76
Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance
Gastaldelli, A., Abdul‐Ghani, M. A., & DeFronzo, R. A. (2020) · Diabetes · doi:10.2337/db19-1152 · Cited by 79
Cameron, N. A., Petito, L. C., McCabe, M., Allen, N. B., O’Brien, M. J., Carnethon, M. R., & Khan, S. S. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018799 · Cited by 76
Insulin Clearance in Health and Disease
Najjar, S. M., Caprio, S., & Gastaldelli, A. (2022) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031622-043133 · Cited by 79
Sreedharan, S., Gokulakrishnan, K., Velmurugan, K., Deepa, M., & Mohan, V. (2010) · PubMed · Cited by 76
Guerra, S., & Gastaldelli, A. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.10.016 · Cited by 79
Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
Malnick, S. D. H., Alin, P., Somin, M., & Neuman, M. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416226 · Cited by 78
Hammer, S., van der Meer, R. W., Lamb, H. J., de Boer, H. H., Bax, J. J., Roos, A., Romijn, J. A., & Smit, J. W. A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90413.2008 · Cited by 73
Steven, S., Hollingsworth, K. G., Small, P. K., Woodcock, S. A., Pucci, A., Aribasala, B., Al‐Mrabeh, A., Batterham, R. L., & Taylor, R. (2016) · Diabetic Medicine · doi:10.1111/dme.13257 · Cited by 71
Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes
Chung, S. T., Hsia, D. S., Chacko, S. K., Rodríguez, L. M., & Haymond, M. W. (2014) · Diabetologia · doi:10.1007/s00125-014-3455-x · Cited by 71
Thondam, S. K., Daousi, C., Wilding, J. P. H., Holst, J. J., Ameen, G. I., Yang, C., Whitmore, C., Mora, S., & Cuthbertson, D. J. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00347.2016 · Cited by 71
Gerges, S. H., Wahdan, S. A., Elsherbiny, D. A., & El‐Demerdash, E. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119220 · Cited by 76
Exploring New Drug Targets for Type 2 Diabetes: Success, Challenges and Opportunities
Kanwal, A., Kanwar, N., Bharati, S., Srivastava, P., Singh, S. P., & Amar, S. (2022) · Biomedicines · doi:10.3390/biomedicines10020331 · Cited by 74
Armstrong, M. J., Hazlehurst, J., Hull, D., Guo, K., Borrows, S., Yu, J., Gough, S. C. L., Newsome, P. N., & Tomlinson, J. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12272 · Cited by 69
von Loeffelholz, C., Coldewey, S. M., & Birkenfeld, A. L. (2021) · Cells · doi:10.3390/cells10071822 · Cited by 70
Ectopic fat: the true culprit linking obesity and cardiovascular disease?
Morelli, M., Gaggini, M., Daniele, G., Marraccini, P., Sicari, R., & Gastaldelli, A. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-04-0285 · Cited by 68
Pafili, K., Kahl, S., Mastrototaro, L., Strassburger, K., Pesta, D., Herder, C., Pützer, J., Dewidar, B., Hendlinger, M., Granata, C., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.010 · Cited by 67
Valenti, L. V. C., Rametta, R., Ruscica, M., Dongiovanni, P., Steffani, L., Motta, B. M., Canavesi, E., Fracanzani, A. L., Mozzi, E., Roviaro, G., et al. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-111 · Cited by 67
Tricò, D., Moriconi, D., Berta, R. D., Baldi, S., Quiñones-Galvan, A., Guiducci, L., Taddei, S., Mari, A., & Nannipieri, M. (2021) · Nutrients · doi:10.3390/nu13041345 · Cited by 72
Cai, X., Ji, L., Chen, Y., Yang, W., Zhou, L., Han, X., Zhang, S., & Ji, L. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12625 · Cited by 65
Neutrophil Extracellular Traps and Liver Disease
Hilscher, M. B., & Shah, V. H. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-3399562 · Cited by 66
Kotronen, A., Yki‐Järvinen, H., Sevastianova, K., Bergholm, R., Hakkarainen, A., Pietiläinen, K. H., Juurinen, L., Lundbom, N. M. I., & Sørensen, T. I. A. (2010) · Obesity · doi:10.1038/oby.2010.137 · Cited by 65
Kalavalapalli, S., Leiva, E. G., Lomonaco, R., Chi, X., Shrestha, S., Dillard, R., Budd, J., Romero, J. P., Li, C., Bril, F., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac660 · Cited by 64
Self-citationPioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes
Clarke, G. D., Solis-Herrera, C., Molina-Wilkins, M., Martinez, S., Merovci, A., Cersosimo, E., Chilton, R. J., Iozzo, P., Gastaldelli, A., Abdul-Ghani, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0078 · Cited by 63
Self-citationSchwenzer, N. F., Machann, J., Schraml, C., Springer, L., Ludescher, B., Stefan, N., Häring, H. U., Fritsche, A., Claussen, C. D., & Schick, F. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181f10fe1 · Cited by 63
NAFLD/NASH in patients with type 2 diabetes and related treatment options
Radaelli, M. G., Martucci, F., Perra, S., Accornero, S., Castoldi, G., Lattuada, G., Manzoni, G., & Perseghin, G. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0799-3 · Cited by 63
Visceral fat: A key mediator of NAFLD development and progression
Bansal, S., Vachher, M., Arora, T. K., Kumar, B., & Burman, A. (2023) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2023.200210 · Cited by 69
Anti-diabetic effect of pyroglutamic acid in type 2 diabetic Goto-Kakizaki rats and KK-Aymice
Yoshinari, O., & Igarashi, K. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511001279 · Cited by 62
The role of adipose tissue dysfunction in hepatic insulin resistance and T2D
Sancar, G., & Birkenfeld, A. L. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0115 · Cited by 69
Ferreira, D. M. S., Simão, A. L., Rodrigues, C. M. P., & Castro, R. E. (2014) · FEBS Journal · doi:10.1111/febs.12806 · Cited by 61
Effects of visceral adiposity on glycerol pathways in gluconeogenesis
Neeland, I. J., Hughes, C., Ayers, C. R., Malloy, C. R., & Jin, E. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.11.008 · Cited by 61
Barchetta, I., Cimini, F. A., Capoccia, D., De Gioannis, R., Porzia, A., Mainiero, F., Di Martino, M., Bertoccini, L., De Bernardinis, M., Leonetti, F., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00108 · Cited by 60
Guerra, S., Mocciaro, G., & Gastaldelli, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13695 · Cited by 61
Castillo, Í. M. P., Argilés, J. M. A., Rueda, R., Ramírez, M., & Pedrosa, J. M. L. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09954-9 · Cited by 75
Scherer, T., & Buettner, C. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9190-4 · Cited by 60
Guiu, B., Loffroy, R., Petit, J., Aho, S., Salem, D. B., Masson, D., Hillon, P., Cercueil, J., & Krause, D. (2009) · European Radiology · doi:10.1007/s00330-009-1330-9 · Cited by 60
Extrahepatic Complications of Nonalcoholic Fatty Liver Disease
Chacko, K. R., & Reinus, J. F. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.004 · Cited by 60
Brouwers, B., Schrauwen-Hinderling, V. B., Jelenik, T., Gemmink, A., Havekes, B., Bruls, Y., Dahlmans, D., Roden, M., Hesselink, M. K. C., & Schrauwen, P. (2017) · Clinical Science · doi:10.1042/cs20170261 · Cited by 59
Ciardullo, S., Oltolini, A., Cannistraci, R., Muraca, E., & Perseghin, G. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac059 · Cited by 61
Borel, A., Nazare, J., Smith, J. D., Aschner, P. J., Barter, P. J., Gaal, L. V., Tan, C., Wïttchen, H., Matsuzawa, Y., Kadowaki, T., et al. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.163 · Cited by 58
Tarantino, G., Finelli, C., Colao, A., Capone, D., Tarantino, M., Grimaldi, E., Chianese, D., Gioia, S., Pasanisi, F., Contaldo, F., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-50 · Cited by 59
Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention
Otten, J., Mellberg, C., Ryberg, M., Sandberg, S., Kullberg, J., Lindahl, B., Larsson, C. L., Hauksson, J. B., & Olsson, T. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.4 · Cited by 60
Adetunji, C. O., Michael, O. S., Rathee, S., Singh, K. R., Ajayi, O. O., Adetunji, J. B., Ojha, A., Singh, J., & Singh, R. P. (2021) · Materials Today Advances · doi:10.1016/j.mtadv.2021.100198 · Cited by 62
Mapping body fat distribution: A key step towards the identification of the vulnerable patient?
Arsenault, B. J., Pelletier-Beaumont, É., Després, J., & Larose, É. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.605387 · Cited by 57
The Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Disease
Perseghin, G. (2010) · Digestive Diseases · doi:10.1159/000282088 · Cited by 57
MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease
Μacut, D., Antić, I. B., Bjekić-Macut, J., & Τζιόμαλος, Κ. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1063 · Cited by 58
Yin, D., Gao, Q., Li, L., Yan, W., Williams, P. E., McGuinness, O. P., Wasserman, D. H., & Abumrad, N. N. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e3182197035 · Cited by 57
Non‐alcoholic fatty liver disease
Tuyama, A. C., & Chang, C. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00204.x · Cited by 58
Ip, B. C., Chun, L., Lichtenstein, A. H., Lintig, J. V., & Wang, X.-D. (2014) · Journal of Nutrition · doi:10.3945/jn.114.200238 · Cited by 56
Sargeant, J. A., Aithal, G. P., Takamura, T., Misu, H., Takayama, H., Douglas, J. A., Turner, M. C., Stensel, D. J., Nimmo, M. A., Webb, D. R., et al. (2018) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0639 · Cited by 56
Maciejewska, D., Ossowski, P., Drozd, A., Ryterská, K., Jamioł-Milc, D., Banaszczak, M., Kaczorowska, M., Sabinicz, A., Raszeja‐Wyszomirska, J., & Stachowska, E. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.09.003 · Cited by 55
Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome
Salomone, F., & Bugianesi, E. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.013 · Cited by 56
Ectopic Lipid Deposition Is Associated With Insulin Resistance in Postmenopausal Women
Abildgaard, J., Danielsen, E. R., Dorph, E., Thomsen, C. E., Juul, A., Ewertsen, C., Pedersen, B. K., Pedersen, A. T., Ploug, T., & Lindegaard, B. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00554 · Cited by 60
Azevedo, V. Z., Silaghi, C. A., Maurel, T., Silaghi, H., Ratziu, V., & Pais, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.774030 · Cited by 59
Wang, S., Kamat, A., Pérgola, P. E., Swamy, A., Tio, F. O., & Cusi, K. J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.001 · Cited by 55
Li, Y., Wang, J., Gu, T., Yamahara, J., & Li, Y. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.03.016 · Cited by 59
Current strategies for the inhibition of hepatic glucose production in type 2 diabetes
Dale, S. E. (2009) · Frontiers in bioscience · doi:10.2741/3301 · Cited by 55
The Role and Mechanisms of Selenium Supplementation on Fatty Liver-Associated Disorder
Xu, L., Lu, Y., Wang, N., & Feng, Y. (2022) · Antioxidants · doi:10.3390/antiox11050922 · Cited by 53
Hiruma, S., Shigiyama, F., & Kumashiro, N. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15006 · Cited by 54
Metadata
- Authors
- Gastaldelli, A., Cusi, K., Pettiti, M., Hardies, J., Miyazaki, Y., Berria, R., Buzzigoli, E., Sironi, A. M., Cersosimo, E., Ferrannini, E., & DeFronzo, R. A.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Istituto di Fisiologia Clinica (IT)
- University of Pisa (IT)
- Corresponding author
- Gastaldelli, Amalia
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 133
- Issue
- 2
- Pages
- 496-506
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2136226749
- Cited by
- 629
- References
- 43
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 33 · 2023: 40 · 2022: 40 · 2021: 40 · 2020: 27 · 2019: 41 · 2018: 36 · 2017: 47 · 2016: 34 · 2015: 26 · 2014: 39 · 2013: 37 · 2012: 33
- FWCI
- 16.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 24092)
- National Center for Research Resources (M01RR01346, M01RR001346)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- hepatic insulin resistance, visceral fat, liver fat, abdominal fat accumulation, type 2 diabetes, obesity, hepatic glucose production, gluconeogenesis, hepatic steatosis, hyperinsulinemic-euglycemic clamp, subcutaneous adipose tissue, hepatic lipid accumulation, hepatic lipogenesis, hepatic lipolysis
- MeSH terms
- Adult, Aging, Blood Glucose, Diabetes Mellitus, Type 2, Female, Gluconeogenesis, Humans, Insulin, Insulin Resistance, Liver, Magnetic Resonance Imaging, Male, Middle Aged, Magnetic Resonance Spectroscopy, Obesity, Glucose Clamp Technique, Body Mass Index, Abdominal Fat, Glycogenolysis, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review